nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2C9—brain cancer	0.536	1	CbGaD
Trimipramine—CYP2D6—Lomustine—brain cancer	0.0478	0.282	CbGbCtD
Trimipramine—CYP2D6—Hydroxyurea—brain cancer	0.0362	0.213	CbGbCtD
Trimipramine—CYP3A4—Temozolomide—brain cancer	0.0357	0.211	CbGbCtD
Trimipramine—CYP3A4—Lomustine—brain cancer	0.0304	0.179	CbGbCtD
Trimipramine—ABCB1—Etoposide—brain cancer	0.0123	0.0722	CbGbCtD
Trimipramine—HTR1D—meninx—brain cancer	0.0102	0.0767	CbGeAlD
Trimipramine—HTR3A—fourth ventricle—brain cancer	0.00996	0.0747	CbGeAlD
Trimipramine—HTR1D—dura mater—brain cancer	0.00941	0.0706	CbGeAlD
Trimipramine—HTR2C—choroid plexus—brain cancer	0.00792	0.0594	CbGeAlD
Trimipramine—CYP3A4—Etoposide—brain cancer	0.00734	0.0433	CbGbCtD
Trimipramine—HTR1D—trigeminal nerve—brain cancer	0.00405	0.0303	CbGeAlD
Trimipramine—HTR2A—choroid plexus—brain cancer	0.00398	0.0298	CbGeAlD
Trimipramine—HTR3A—cranial nerve—brain cancer	0.00355	0.0266	CbGeAlD
Trimipramine—Throat sore—Lomustine—brain cancer	0.00334	0.0279	CcSEcCtD
Trimipramine—Oropharyngeal discomfort—Lomustine—brain cancer	0.00331	0.0276	CcSEcCtD
Trimipramine—HRH1—nose—brain cancer	0.00307	0.023	CbGeAlD
Trimipramine—HTR1D—cranial nerve—brain cancer	0.00288	0.0216	CbGeAlD
Trimipramine—Oropharyngeal pain—Lomustine—brain cancer	0.00264	0.0221	CcSEcCtD
Trimipramine—SLC6A3—telencephalic ventricle—brain cancer	0.0024	0.018	CbGeAlD
Trimipramine—HTR1D—telencephalic ventricle—brain cancer	0.00234	0.0176	CbGeAlD
Trimipramine—HTR2C—telencephalic ventricle—brain cancer	0.00232	0.0174	CbGeAlD
Trimipramine—HTR2A—trigeminal nerve—brain cancer	0.00201	0.0151	CbGeAlD
Trimipramine—HTR2A—cerebellar cortex—brain cancer	0.002	0.015	CbGeAlD
Trimipramine—HTR1A—telencephalic ventricle—brain cancer	0.00195	0.0146	CbGeAlD
Trimipramine—Disorientation—Lomustine—brain cancer	0.00195	0.0163	CcSEcCtD
Trimipramine—Tongue discolouration—Temozolomide—brain cancer	0.00191	0.0159	CcSEcCtD
Trimipramine—Petechiae—Procarbazine—brain cancer	0.00186	0.0155	CcSEcCtD
Trimipramine—HTR2A—vein—brain cancer	0.00182	0.0136	CbGeAlD
Trimipramine—HTR3A—ganglion—brain cancer	0.0018	0.0135	CbGeAlD
Trimipramine—DRD2—telencephalic ventricle—brain cancer	0.00177	0.0132	CbGeAlD
Trimipramine—Bone marrow depression—Hydroxyurea—brain cancer	0.00175	0.0146	CcSEcCtD
Trimipramine—Ataxia—Lomustine—brain cancer	0.00164	0.0137	CcSEcCtD
Trimipramine—SLC6A3—ganglion—brain cancer	0.00149	0.0112	CbGeAlD
Trimipramine—Nightmare—Procarbazine—brain cancer	0.00147	0.0123	CcSEcCtD
Trimipramine—HTR1D—ganglion—brain cancer	0.00146	0.0109	CbGeAlD
Trimipramine—HTR2C—ganglion—brain cancer	0.00145	0.0108	CbGeAlD
Trimipramine—Pancytopenia—Lomustine—brain cancer	0.00143	0.012	CcSEcCtD
Trimipramine—HTR2A—cranial nerve—brain cancer	0.00143	0.0107	CbGeAlD
Trimipramine—HTR2A—pons—brain cancer	0.00142	0.0106	CbGeAlD
Trimipramine—SLC6A4—ganglion—brain cancer	0.00137	0.0103	CbGeAlD
Trimipramine—Gynaecomastia—Procarbazine—brain cancer	0.00137	0.0114	CcSEcCtD
Trimipramine—Stomatitis—Lomustine—brain cancer	0.00131	0.0109	CcSEcCtD
Trimipramine—Vascular purpura—Procarbazine—brain cancer	0.00124	0.0103	CcSEcCtD
Trimipramine—Disorientation—Procarbazine—brain cancer	0.00124	0.0103	CcSEcCtD
Trimipramine—Extrapyramidal disorder—Temozolomide—brain cancer	0.00123	0.0102	CcSEcCtD
Trimipramine—HTR1A—ganglion—brain cancer	0.00122	0.00912	CbGeAlD
Trimipramine—SLC6A2—ganglion—brain cancer	0.00121	0.00904	CbGeAlD
Trimipramine—HTR2A—telencephalic ventricle—brain cancer	0.00116	0.00873	CbGeAlD
Trimipramine—HTR1D—blood vessel—brain cancer	0.00116	0.0087	CbGeAlD
Trimipramine—Purpura—Procarbazine—brain cancer	0.00115	0.0096	CcSEcCtD
Trimipramine—SLC6A3—hindbrain—brain cancer	0.00113	0.0085	CbGeAlD
Trimipramine—Petechiae—Temozolomide—brain cancer	0.00112	0.00937	CcSEcCtD
Trimipramine—DRD2—ganglion—brain cancer	0.0011	0.00824	CbGeAlD
Trimipramine—Alopecia—Lomustine—brain cancer	0.00107	0.00891	CcSEcCtD
Trimipramine—Ataxia—Procarbazine—brain cancer	0.00104	0.0087	CcSEcCtD
Trimipramine—SLC6A4—hindbrain—brain cancer	0.00104	0.00779	CbGeAlD
Trimipramine—HTR2A—pineal body—brain cancer	0.00101	0.00757	CbGeAlD
Trimipramine—Coordination abnormal—Carmustine—brain cancer	0.000973	0.00812	CcSEcCtD
Trimipramine—Disorientation—Hydroxyurea—brain cancer	0.000959	0.008	CcSEcCtD
Trimipramine—Eosinophilia—Procarbazine—brain cancer	0.000949	0.00792	CcSEcCtD
Trimipramine—Coordination abnormal—Temozolomide—brain cancer	0.00094	0.00785	CcSEcCtD
Trimipramine—HTR1A—hindbrain—brain cancer	0.000923	0.00692	CbGeAlD
Trimipramine—Tingling sensation—Etoposide—brain cancer	0.000919	0.00767	CcSEcCtD
Trimipramine—Pancytopenia—Procarbazine—brain cancer	0.00091	0.00759	CcSEcCtD
Trimipramine—Numbness—Etoposide—brain cancer	0.000891	0.00744	CcSEcCtD
Trimipramine—Pollakiuria—Procarbazine—brain cancer	0.000885	0.00739	CcSEcCtD
Trimipramine—Gynaecomastia—Carmustine—brain cancer	0.000855	0.00713	CcSEcCtD
Trimipramine—Drowsiness—Procarbazine—brain cancer	0.000854	0.00713	CcSEcCtD
Trimipramine—Sensory loss—Etoposide—brain cancer	0.000853	0.00712	CcSEcCtD
Trimipramine—ADRA1A—hindbrain—brain cancer	0.00085	0.00637	CbGeAlD
Trimipramine—Thrombocytopenia—Lomustine—brain cancer	0.00084	0.00701	CcSEcCtD
Trimipramine—Neuropathy peripheral—Procarbazine—brain cancer	0.000837	0.00699	CcSEcCtD
Trimipramine—DRD2—hindbrain—brain cancer	0.000834	0.00625	CbGeAlD
Trimipramine—Jaundice—Procarbazine—brain cancer	0.000833	0.00695	CcSEcCtD
Trimipramine—Stomatitis—Procarbazine—brain cancer	0.000833	0.00695	CcSEcCtD
Trimipramine—Anorexia—Lomustine—brain cancer	0.000818	0.00683	CcSEcCtD
Trimipramine—HTR3A—brainstem—brain cancer	0.000781	0.00585	CbGeAlD
Trimipramine—Body temperature increased—Carboplatin—brain cancer	0.000775	0.00647	CcSEcCtD
Trimipramine—Hallucination—Procarbazine—brain cancer	0.000763	0.00637	CcSEcCtD
Trimipramine—Vascular purpura—Temozolomide—brain cancer	0.000749	0.00625	CcSEcCtD
Trimipramine—Decreased appetite—Lomustine—brain cancer	0.000746	0.00623	CcSEcCtD
Trimipramine—HTR2A—ganglion—brain cancer	0.000725	0.00543	CbGeAlD
Trimipramine—Flushing—Procarbazine—brain cancer	0.000712	0.00594	CcSEcCtD
Trimipramine—Pancytopenia—Hydroxyurea—brain cancer	0.000704	0.00588	CcSEcCtD
Trimipramine—Purpura—Temozolomide—brain cancer	0.000695	0.0058	CcSEcCtD
Trimipramine—HTR3A—telencephalon—brain cancer	0.000693	0.0052	CbGeAlD
Trimipramine—Arrhythmia—Procarbazine—brain cancer	0.000685	0.00572	CcSEcCtD
Trimipramine—Body temperature increased—Lomustine—brain cancer	0.000678	0.00566	CcSEcCtD
Trimipramine—Alopecia—Procarbazine—brain cancer	0.000678	0.00566	CcSEcCtD
Trimipramine—Weight increased—Hydroxyurea—brain cancer	0.000675	0.00563	CcSEcCtD
Trimipramine—Drowsiness—Hydroxyurea—brain cancer	0.000661	0.00552	CcSEcCtD
Trimipramine—Ataxia—Carmustine—brain cancer	0.000652	0.00544	CcSEcCtD
Trimipramine—SLC6A3—brainstem—brain cancer	0.00065	0.00487	CbGeAlD
Trimipramine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000648	0.00541	CcSEcCtD
Trimipramine—Stomatitis—Hydroxyurea—brain cancer	0.000644	0.00538	CcSEcCtD
Trimipramine—HTR1D—brainstem—brain cancer	0.000634	0.00476	CbGeAlD
Trimipramine—Ataxia—Temozolomide—brain cancer	0.00063	0.00526	CcSEcCtD
Trimipramine—HTR2C—brainstem—brain cancer	0.000628	0.00471	CbGeAlD
Trimipramine—Tremor—Procarbazine—brain cancer	0.000625	0.00522	CcSEcCtD
Trimipramine—HTR2A—endothelium—brain cancer	0.000625	0.00469	CbGeAlD
Trimipramine—SLC6A4—brainstem—brain cancer	0.000595	0.00446	CbGeAlD
Trimipramine—Hallucination—Hydroxyurea—brain cancer	0.000591	0.00493	CcSEcCtD
Trimipramine—Convulsion—Procarbazine—brain cancer	0.000578	0.00483	CcSEcCtD
Trimipramine—SLC6A3—telencephalon—brain cancer	0.000577	0.00432	CbGeAlD
Trimipramine—HTR2A—blood vessel—brain cancer	0.000576	0.00432	CbGeAlD
Trimipramine—Hypertension—Procarbazine—brain cancer	0.000576	0.00481	CcSEcCtD
Trimipramine—Pancytopenia—Carmustine—brain cancer	0.000569	0.00475	CcSEcCtD
Trimipramine—Anxiety—Procarbazine—brain cancer	0.000566	0.00473	CcSEcCtD
Trimipramine—HTR1D—telencephalon—brain cancer	0.000563	0.00422	CbGeAlD
Trimipramine—HTR2C—telencephalon—brain cancer	0.000557	0.00418	CbGeAlD
Trimipramine—Dry mouth—Procarbazine—brain cancer	0.000556	0.00464	CcSEcCtD
Trimipramine—Pancytopenia—Temozolomide—brain cancer	0.00055	0.00459	CcSEcCtD
Trimipramine—HTR2A—hindbrain—brain cancer	0.00055	0.00412	CbGeAlD
Trimipramine—Confusional state—Procarbazine—brain cancer	0.000549	0.00458	CcSEcCtD
Trimipramine—Vomiting—Lomustine—brain cancer	0.000546	0.00455	CcSEcCtD
Trimipramine—Oedema—Procarbazine—brain cancer	0.000545	0.00455	CcSEcCtD
Trimipramine—Pollakiuria—Temozolomide—brain cancer	0.000535	0.00447	CcSEcCtD
Trimipramine—Erectile dysfunction—Temozolomide—brain cancer	0.000533	0.00445	CcSEcCtD
Trimipramine—Thrombocytopenia—Procarbazine—brain cancer	0.000533	0.00445	CcSEcCtD
Trimipramine—Tachycardia—Procarbazine—brain cancer	0.000532	0.00444	CcSEcCtD
Trimipramine—HTR1A—brainstem—brain cancer	0.000529	0.00396	CbGeAlD
Trimipramine—SLC6A4—telencephalon—brain cancer	0.000528	0.00396	CbGeAlD
Trimipramine—Weight increased—Temozolomide—brain cancer	0.000527	0.0044	CcSEcCtD
Trimipramine—Alopecia—Hydroxyurea—brain cancer	0.000524	0.00438	CcSEcCtD
Trimipramine—SLC6A2—brainstem—brain cancer	0.000524	0.00393	CbGeAlD
Trimipramine—Neuropathy peripheral—Carmustine—brain cancer	0.000524	0.00437	CcSEcCtD
Trimipramine—Stomatitis—Carmustine—brain cancer	0.000521	0.00435	CcSEcCtD
Trimipramine—Anorexia—Procarbazine—brain cancer	0.000519	0.00433	CcSEcCtD
Trimipramine—Nausea—Lomustine—brain cancer	0.00051	0.00425	CcSEcCtD
Trimipramine—Hypotension—Procarbazine—brain cancer	0.000509	0.00425	CcSEcCtD
Trimipramine—Neuropathy peripheral—Temozolomide—brain cancer	0.000506	0.00423	CcSEcCtD
Trimipramine—Stomatitis—Temozolomide—brain cancer	0.000503	0.0042	CcSEcCtD
Trimipramine—CYP2D6—hindbrain—brain cancer	0.000501	0.00375	CbGeAlD
Trimipramine—Insomnia—Procarbazine—brain cancer	0.000493	0.00411	CcSEcCtD
Trimipramine—Paraesthesia—Procarbazine—brain cancer	0.000489	0.00408	CcSEcCtD
Trimipramine—ADRA1A—brainstem—brain cancer	0.000487	0.00365	CbGeAlD
Trimipramine—Somnolence—Procarbazine—brain cancer	0.000484	0.00404	CcSEcCtD
Trimipramine—ADRA1B—head—brain cancer	0.000479	0.00359	CbGeAlD
Trimipramine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000479	0.004	CcSEcCtD
Trimipramine—DRD2—brainstem—brain cancer	0.000478	0.00358	CbGeAlD
Trimipramine—Hallucination—Carmustine—brain cancer	0.000477	0.00398	CcSEcCtD
Trimipramine—Hypoaesthesia—Carmustine—brain cancer	0.000477	0.00398	CcSEcCtD
Trimipramine—Decreased appetite—Procarbazine—brain cancer	0.000474	0.00395	CcSEcCtD
Trimipramine—Fatigue—Procarbazine—brain cancer	0.00047	0.00392	CcSEcCtD
Trimipramine—HTR1A—telencephalon—brain cancer	0.000469	0.00352	CbGeAlD
Trimipramine—Malaise—Hydroxyurea—brain cancer	0.000466	0.00389	CcSEcCtD
Trimipramine—Constipation—Procarbazine—brain cancer	0.000466	0.00389	CcSEcCtD
Trimipramine—SLC6A2—telencephalon—brain cancer	0.000465	0.00349	CbGeAlD
Trimipramine—Hallucination—Temozolomide—brain cancer	0.000461	0.00385	CcSEcCtD
Trimipramine—Hypoaesthesia—Temozolomide—brain cancer	0.000461	0.00385	CcSEcCtD
Trimipramine—Feeling abnormal—Procarbazine—brain cancer	0.000449	0.00375	CcSEcCtD
Trimipramine—Convulsion—Hydroxyurea—brain cancer	0.000448	0.00374	CcSEcCtD
Trimipramine—Flushing—Carmustine—brain cancer	0.000445	0.00372	CcSEcCtD
Trimipramine—Pancytopenia—Etoposide—brain cancer	0.00044	0.00367	CcSEcCtD
Trimipramine—HTR2C—medulla oblongata—brain cancer	0.000438	0.00328	CbGeAlD
Trimipramine—ADRA1B—central nervous system—brain cancer	0.000438	0.00328	CbGeAlD
Trimipramine—Discomfort—Hydroxyurea—brain cancer	0.000435	0.00363	CcSEcCtD
Trimipramine—Urticaria—Procarbazine—brain cancer	0.000433	0.00361	CcSEcCtD
Trimipramine—ADRA1A—telencephalon—brain cancer	0.000433	0.00324	CbGeAlD
Trimipramine—Tinnitus—Temozolomide—brain cancer	0.000432	0.00361	CcSEcCtD
Trimipramine—HTR3A—head—brain cancer	0.000432	0.00324	CbGeAlD
Trimipramine—Body temperature increased—Procarbazine—brain cancer	0.000431	0.00359	CcSEcCtD
Trimipramine—Abdominal pain—Procarbazine—brain cancer	0.000431	0.00359	CcSEcCtD
Trimipramine—Flushing—Temozolomide—brain cancer	0.00043	0.00359	CcSEcCtD
Trimipramine—Arrhythmia—Carmustine—brain cancer	0.000429	0.00358	CcSEcCtD
Trimipramine—DRD2—telencephalon—brain cancer	0.000424	0.00318	CbGeAlD
Trimipramine—Alopecia—Carmustine—brain cancer	0.000424	0.00354	CcSEcCtD
Trimipramine—Oedema—Hydroxyurea—brain cancer	0.000422	0.00352	CcSEcCtD
Trimipramine—SLC6A3—midbrain—brain cancer	0.000414	0.0031	CbGeAlD
Trimipramine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000413	0.00345	CcSEcCtD
Trimipramine—Alopecia—Temozolomide—brain cancer	0.00041	0.00342	CcSEcCtD
Trimipramine—Acute coronary syndrome—Etoposide—brain cancer	0.000407	0.0034	CcSEcCtD
Trimipramine—Neuropathy peripheral—Etoposide—brain cancer	0.000405	0.00338	CcSEcCtD
Trimipramine—Myocardial infarction—Etoposide—brain cancer	0.000405	0.00338	CcSEcCtD
Trimipramine—HTR1D—midbrain—brain cancer	0.000404	0.00303	CbGeAlD
Trimipramine—SLC6A3—spinal cord—brain cancer	0.000404	0.00303	CbGeAlD
Trimipramine—Stomatitis—Etoposide—brain cancer	0.000403	0.00336	CcSEcCtD
Trimipramine—Jaundice—Etoposide—brain cancer	0.000403	0.00336	CcSEcCtD
Trimipramine—Anorexia—Hydroxyurea—brain cancer	0.000402	0.00335	CcSEcCtD
Trimipramine—HTR2C—midbrain—brain cancer	0.0004	0.003	CbGeAlD
Trimipramine—Dextropropoxyphene—CYP2C9—brain cancer	0.000399	0.152	CrCbGaD
Trimipramine—Dysgeusia—Temozolomide—brain cancer	0.000395	0.0033	CcSEcCtD
Trimipramine—HTR3A—central nervous system—brain cancer	0.000394	0.00295	CbGeAlD
Trimipramine—Vision blurred—Carmustine—brain cancer	0.000394	0.00329	CcSEcCtD
Trimipramine—Tremor—Carmustine—brain cancer	0.000391	0.00327	CcSEcCtD
Trimipramine—Asthenia—Procarbazine—brain cancer	0.000391	0.00326	CcSEcCtD
Trimipramine—HTR2C—spinal cord—brain cancer	0.000391	0.00293	CbGeAlD
Trimipramine—SLC6A2—gonad—brain cancer	0.000388	0.00291	CbGeAlD
Trimipramine—Agranulocytosis—Etoposide—brain cancer	0.000386	0.00322	CcSEcCtD
Trimipramine—Pruritus—Procarbazine—brain cancer	0.000385	0.00322	CcSEcCtD
Trimipramine—Agitation—Carmustine—brain cancer	0.000384	0.0032	CcSEcCtD
Trimipramine—Vision blurred—Temozolomide—brain cancer	0.00038	0.00317	CcSEcCtD
Trimipramine—SLC6A4—midbrain—brain cancer	0.00038	0.00284	CbGeAlD
Trimipramine—Tremor—Temozolomide—brain cancer	0.000378	0.00316	CcSEcCtD
Trimipramine—ABCB1—blood vessel—brain cancer	0.000378	0.00283	CbGeAlD
Trimipramine—Somnolence—Hydroxyurea—brain cancer	0.000375	0.00313	CcSEcCtD
Trimipramine—Ill-defined disorder—Temozolomide—brain cancer	0.000374	0.00313	CcSEcCtD
Trimipramine—Diarrhoea—Procarbazine—brain cancer	0.000373	0.00311	CcSEcCtD
Trimipramine—Dyspepsia—Hydroxyurea—brain cancer	0.000371	0.0031	CcSEcCtD
Trimipramine—Agitation—Temozolomide—brain cancer	0.000371	0.0031	CcSEcCtD
Trimipramine—SLC6A4—spinal cord—brain cancer	0.00037	0.00278	CbGeAlD
Trimipramine—Hypoaesthesia—Etoposide—brain cancer	0.000369	0.00308	CcSEcCtD
Trimipramine—Carbamazepine—CYP2C9—brain cancer	0.000368	0.141	CrCbGaD
Trimipramine—Decreased appetite—Hydroxyurea—brain cancer	0.000367	0.00306	CcSEcCtD
Trimipramine—SLC6A2—medulla oblongata—brain cancer	0.000366	0.00274	CbGeAlD
Trimipramine—Malaise—Temozolomide—brain cancer	0.000364	0.00304	CcSEcCtD
Trimipramine—Fatigue—Hydroxyurea—brain cancer	0.000364	0.00303	CcSEcCtD
Trimipramine—Convulsion—Carmustine—brain cancer	0.000362	0.00302	CcSEcCtD
Trimipramine—Hypertension—Carmustine—brain cancer	0.000361	0.00301	CcSEcCtD
Trimipramine—Constipation—Hydroxyurea—brain cancer	0.000361	0.00301	CcSEcCtD
Trimipramine—Dizziness—Procarbazine—brain cancer	0.00036	0.00301	CcSEcCtD
Trimipramine—SLC6A3—head—brain cancer	0.000359	0.00269	CbGeAlD
Trimipramine—Palpitations—Temozolomide—brain cancer	0.000357	0.00298	CcSEcCtD
Trimipramine—Anxiety—Carmustine—brain cancer	0.000354	0.00296	CcSEcCtD
Trimipramine—HTR1D—head—brain cancer	0.000351	0.00263	CbGeAlD
Trimipramine—Convulsion—Temozolomide—brain cancer	0.00035	0.00292	CcSEcCtD
Trimipramine—Hypertension—Temozolomide—brain cancer	0.000348	0.00291	CcSEcCtD
Trimipramine—Feeling abnormal—Hydroxyurea—brain cancer	0.000347	0.0029	CcSEcCtD
Trimipramine—ADRA1B—brain—brain cancer	0.000347	0.0026	CbGeAlD
Trimipramine—HTR2C—head—brain cancer	0.000347	0.0026	CbGeAlD
Trimipramine—Vomiting—Procarbazine—brain cancer	0.000346	0.00289	CcSEcCtD
Trimipramine—DRD2—pituitary gland—brain cancer	0.000345	0.00259	CbGeAlD
Trimipramine—Flushing—Etoposide—brain cancer	0.000344	0.00287	CcSEcCtD
Trimipramine—Confusional state—Carmustine—brain cancer	0.000344	0.00287	CcSEcCtD
Trimipramine—Rash—Procarbazine—brain cancer	0.000344	0.00287	CcSEcCtD
Trimipramine—Dermatitis—Procarbazine—brain cancer	0.000343	0.00286	CcSEcCtD
Trimipramine—Anxiety—Temozolomide—brain cancer	0.000342	0.00286	CcSEcCtD
Trimipramine—Headache—Procarbazine—brain cancer	0.000341	0.00285	CcSEcCtD
Trimipramine—Oedema—Carmustine—brain cancer	0.000341	0.00284	CcSEcCtD
Trimipramine—Discomfort—Temozolomide—brain cancer	0.000339	0.00283	CcSEcCtD
Trimipramine—HTR1A—midbrain—brain cancer	0.000337	0.00253	CbGeAlD
Trimipramine—Dry mouth—Temozolomide—brain cancer	0.000336	0.0028	CcSEcCtD
Trimipramine—HRH1—telencephalon—brain cancer	0.000335	0.00251	CbGeAlD
Trimipramine—Thrombocytopenia—Carmustine—brain cancer	0.000334	0.00279	CcSEcCtD
Trimipramine—SLC6A4—endocrine gland—brain cancer	0.000333	0.0025	CbGeAlD
Trimipramine—Body temperature increased—Hydroxyurea—brain cancer	0.000333	0.00278	CcSEcCtD
Trimipramine—Tachycardia—Carmustine—brain cancer	0.000333	0.00278	CcSEcCtD
Trimipramine—Confusional state—Temozolomide—brain cancer	0.000332	0.00277	CcSEcCtD
Trimipramine—Oedema—Temozolomide—brain cancer	0.000329	0.00275	CcSEcCtD
Trimipramine—SLC6A4—head—brain cancer	0.000329	0.00247	CbGeAlD
Trimipramine—ADRA2A—telencephalon—brain cancer	0.000329	0.00247	CbGeAlD
Trimipramine—HTR1A—spinal cord—brain cancer	0.000329	0.00246	CbGeAlD
Trimipramine—Alopecia—Etoposide—brain cancer	0.000328	0.00274	CcSEcCtD
Trimipramine—SLC6A3—central nervous system—brain cancer	0.000328	0.00246	CbGeAlD
Trimipramine—Anorexia—Carmustine—brain cancer	0.000325	0.00271	CcSEcCtD
Trimipramine—Nausea—Procarbazine—brain cancer	0.000324	0.0027	CcSEcCtD
Trimipramine—Thrombocytopenia—Temozolomide—brain cancer	0.000323	0.00269	CcSEcCtD
Trimipramine—SLC6A3—cerebellum—brain cancer	0.00032	0.0024	CbGeAlD
Trimipramine—HTR1D—central nervous system—brain cancer	0.00032	0.0024	CbGeAlD
Trimipramine—Hypotension—Carmustine—brain cancer	0.000319	0.00266	CcSEcCtD
Trimipramine—HTR2C—central nervous system—brain cancer	0.000317	0.00238	CbGeAlD
Trimipramine—Dysgeusia—Etoposide—brain cancer	0.000316	0.00264	CcSEcCtD
Trimipramine—HTR2A—brainstem—brain cancer	0.000315	0.00236	CbGeAlD
Trimipramine—Anorexia—Temozolomide—brain cancer	0.000314	0.00262	CcSEcCtD
Trimipramine—HTR3A—brain—brain cancer	0.000313	0.00234	CbGeAlD
Trimipramine—Insomnia—Carmustine—brain cancer	0.000308	0.00257	CcSEcCtD
Trimipramine—Paraesthesia—Carmustine—brain cancer	0.000306	0.00255	CcSEcCtD
Trimipramine—DRD2—midbrain—brain cancer	0.000304	0.00228	CbGeAlD
Trimipramine—Nortriptyline—CYP2C9—brain cancer	0.000303	0.116	CrCbGaD
Trimipramine—Somnolence—Carmustine—brain cancer	0.000303	0.00253	CcSEcCtD
Trimipramine—Asthenia—Hydroxyurea—brain cancer	0.000303	0.00252	CcSEcCtD
Trimipramine—SLC6A4—central nervous system—brain cancer	0.0003	0.00225	CbGeAlD
Trimipramine—Ill-defined disorder—Etoposide—brain cancer	0.0003	0.0025	CcSEcCtD
Trimipramine—Insomnia—Temozolomide—brain cancer	0.000298	0.00249	CcSEcCtD
Trimipramine—Decreased appetite—Carmustine—brain cancer	0.000296	0.00247	CcSEcCtD
Trimipramine—HTR1A—endocrine gland—brain cancer	0.000296	0.00222	CbGeAlD
Trimipramine—Paraesthesia—Temozolomide—brain cancer	0.000296	0.00247	CcSEcCtD
Trimipramine—SLC6A2—endocrine gland—brain cancer	0.000293	0.0022	CbGeAlD
Trimipramine—Somnolence—Temozolomide—brain cancer	0.000293	0.00244	CcSEcCtD
Trimipramine—HTR1A—head—brain cancer	0.000292	0.00219	CbGeAlD
Trimipramine—Constipation—Carmustine—brain cancer	0.000291	0.00243	CcSEcCtD
Trimipramine—Malaise—Etoposide—brain cancer	0.000291	0.00243	CcSEcCtD
Trimipramine—Dyspepsia—Temozolomide—brain cancer	0.00029	0.00242	CcSEcCtD
Trimipramine—SLC6A2—head—brain cancer	0.00029	0.00217	CbGeAlD
Trimipramine—Diarrhoea—Hydroxyurea—brain cancer	0.000288	0.00241	CcSEcCtD
Trimipramine—CYP2D6—brainstem—brain cancer	0.000287	0.00215	CbGeAlD
Trimipramine—Decreased appetite—Temozolomide—brain cancer	0.000286	0.00239	CcSEcCtD
Trimipramine—Fatigue—Temozolomide—brain cancer	0.000284	0.00237	CcSEcCtD
Trimipramine—Constipation—Temozolomide—brain cancer	0.000282	0.00235	CcSEcCtD
Trimipramine—Feeling abnormal—Carmustine—brain cancer	0.000281	0.00234	CcSEcCtD
Trimipramine—Diphenhydramine—CYP2C9—brain cancer	0.00028	0.107	CrCbGaD
Trimipramine—Convulsion—Etoposide—brain cancer	0.00028	0.00234	CcSEcCtD
Trimipramine—HTR2A—telencephalon—brain cancer	0.00028	0.0021	CbGeAlD
Trimipramine—Hypertension—Etoposide—brain cancer	0.000279	0.00233	CcSEcCtD
Trimipramine—Dizziness—Hydroxyurea—brain cancer	0.000279	0.00233	CcSEcCtD
Trimipramine—CYP2C19—endocrine gland—brain cancer	0.000276	0.00207	CbGeAlD
Trimipramine—Promethazine—CYP2C9—brain cancer	0.000275	0.105	CrCbGaD
Trimipramine—ADRA2A—gonad—brain cancer	0.000274	0.00206	CbGeAlD
Trimipramine—ADRA1A—endocrine gland—brain cancer	0.000273	0.00205	CbGeAlD
Trimipramine—Doxepin—CYP2C9—brain cancer	0.000272	0.104	CrCbGaD
Trimipramine—Discomfort—Etoposide—brain cancer	0.000272	0.00227	CcSEcCtD
Trimipramine—Feeling abnormal—Temozolomide—brain cancer	0.000271	0.00227	CcSEcCtD
Trimipramine—Methadone—CYP2C9—brain cancer	0.000271	0.103	CrCbGaD
Trimipramine—Body temperature increased—Carmustine—brain cancer	0.000269	0.00225	CcSEcCtD
Trimipramine—Abdominal pain—Carmustine—brain cancer	0.000269	0.00225	CcSEcCtD
Trimipramine—ADRA1A—head—brain cancer	0.000269	0.00202	CbGeAlD
Trimipramine—Vomiting—Hydroxyurea—brain cancer	0.000268	0.00224	CcSEcCtD
Trimipramine—ADRA2A—pituitary gland—brain cancer	0.000268	0.00201	CbGeAlD
Trimipramine—DRD2—endocrine gland—brain cancer	0.000267	0.002	CbGeAlD
Trimipramine—HTR1A—central nervous system—brain cancer	0.000267	0.002	CbGeAlD
Trimipramine—Rash—Hydroxyurea—brain cancer	0.000266	0.00222	CcSEcCtD
Trimipramine—Confusional state—Etoposide—brain cancer	0.000266	0.00222	CcSEcCtD
Trimipramine—Dermatitis—Hydroxyurea—brain cancer	0.000266	0.00222	CcSEcCtD
Trimipramine—SLC6A2—central nervous system—brain cancer	0.000264	0.00198	CbGeAlD
Trimipramine—Headache—Hydroxyurea—brain cancer	0.000264	0.0022	CcSEcCtD
Trimipramine—DRD2—head—brain cancer	0.000264	0.00198	CbGeAlD
Trimipramine—Urticaria—Temozolomide—brain cancer	0.000262	0.00218	CcSEcCtD
Trimipramine—HTR1A—cerebellum—brain cancer	0.000261	0.00195	CbGeAlD
Trimipramine—Body temperature increased—Temozolomide—brain cancer	0.00026	0.00217	CcSEcCtD
Trimipramine—Abdominal pain—Temozolomide—brain cancer	0.00026	0.00217	CcSEcCtD
Trimipramine—SLC6A3—brain—brain cancer	0.00026	0.00195	CbGeAlD
Trimipramine—ADRA2A—medulla oblongata—brain cancer	0.000258	0.00194	CbGeAlD
Trimipramine—Thrombocytopenia—Etoposide—brain cancer	0.000258	0.00215	CcSEcCtD
Trimipramine—Tachycardia—Etoposide—brain cancer	0.000257	0.00215	CcSEcCtD
Trimipramine—CYP2D6—telencephalon—brain cancer	0.000255	0.00191	CbGeAlD
Trimipramine—HTR1D—brain—brain cancer	0.000254	0.0019	CbGeAlD
Trimipramine—HTR2C—brain—brain cancer	0.000252	0.00189	CbGeAlD
Trimipramine—Anorexia—Etoposide—brain cancer	0.000251	0.0021	CcSEcCtD
Trimipramine—Nausea—Hydroxyurea—brain cancer	0.00025	0.00209	CcSEcCtD
Trimipramine—Hypotension—Etoposide—brain cancer	0.000246	0.00206	CcSEcCtD
Trimipramine—ADRA1A—central nervous system—brain cancer	0.000246	0.00184	CbGeAlD
Trimipramine—Asthenia—Carmustine—brain cancer	0.000245	0.00204	CcSEcCtD
Trimipramine—Promazine—CYP2C9—brain cancer	0.000242	0.0923	CrCbGaD
Trimipramine—DRD2—central nervous system—brain cancer	0.000241	0.00181	CbGeAlD
Trimipramine—ADRA1A—cerebellum—brain cancer	0.00024	0.0018	CbGeAlD
Trimipramine—SLC6A4—brain—brain cancer	0.000238	0.00179	CbGeAlD
Trimipramine—Paraesthesia—Etoposide—brain cancer	0.000237	0.00198	CcSEcCtD
Trimipramine—Asthenia—Temozolomide—brain cancer	0.000236	0.00197	CcSEcCtD
Trimipramine—ADRA2A—midbrain—brain cancer	0.000236	0.00177	CbGeAlD
Trimipramine—DRD2—cerebellum—brain cancer	0.000236	0.00177	CbGeAlD
Trimipramine—Somnolence—Etoposide—brain cancer	0.000234	0.00196	CcSEcCtD
Trimipramine—HTR2A—gonad—brain cancer	0.000233	0.00175	CbGeAlD
Trimipramine—Diarrhoea—Carmustine—brain cancer	0.000233	0.00195	CcSEcCtD
Trimipramine—Pruritus—Temozolomide—brain cancer	0.000233	0.00195	CcSEcCtD
Trimipramine—ADRA2A—spinal cord—brain cancer	0.00023	0.00173	CbGeAlD
Trimipramine—Decreased appetite—Etoposide—brain cancer	0.000229	0.00191	CcSEcCtD
Trimipramine—HTR2A—pituitary gland—brain cancer	0.000228	0.00171	CbGeAlD
Trimipramine—Fatigue—Etoposide—brain cancer	0.000227	0.0019	CcSEcCtD
Trimipramine—Dizziness—Carmustine—brain cancer	0.000225	0.00188	CcSEcCtD
Trimipramine—Constipation—Etoposide—brain cancer	0.000225	0.00188	CcSEcCtD
Trimipramine—Diarrhoea—Temozolomide—brain cancer	0.000225	0.00188	CcSEcCtD
Trimipramine—HTR2A—medulla oblongata—brain cancer	0.00022	0.00165	CbGeAlD
Trimipramine—Dizziness—Temozolomide—brain cancer	0.000218	0.00182	CcSEcCtD
Trimipramine—Feeling abnormal—Etoposide—brain cancer	0.000217	0.00181	CcSEcCtD
Trimipramine—Vomiting—Carmustine—brain cancer	0.000217	0.00181	CcSEcCtD
Trimipramine—Rash—Carmustine—brain cancer	0.000215	0.00179	CcSEcCtD
Trimipramine—Dermatitis—Carmustine—brain cancer	0.000215	0.00179	CcSEcCtD
Trimipramine—CYP2C9—endocrine gland—brain cancer	0.000214	0.00161	CbGeAlD
Trimipramine—Headache—Carmustine—brain cancer	0.000214	0.00178	CcSEcCtD
Trimipramine—HTR1A—brain—brain cancer	0.000212	0.00159	CbGeAlD
Trimipramine—HRH1—endocrine gland—brain cancer	0.000211	0.00158	CbGeAlD
Trimipramine—Amitriptyline—CYP2C9—brain cancer	0.00021	0.0803	CrCbGaD
Trimipramine—SLC6A2—brain—brain cancer	0.00021	0.00157	CbGeAlD
Trimipramine—Vomiting—Temozolomide—brain cancer	0.000209	0.00175	CcSEcCtD
Trimipramine—Urticaria—Etoposide—brain cancer	0.000209	0.00175	CcSEcCtD
Trimipramine—HRH1—head—brain cancer	0.000208	0.00156	CbGeAlD
Trimipramine—Body temperature increased—Etoposide—brain cancer	0.000208	0.00174	CcSEcCtD
Trimipramine—Abdominal pain—Etoposide—brain cancer	0.000208	0.00174	CcSEcCtD
Trimipramine—Rash—Temozolomide—brain cancer	0.000208	0.00173	CcSEcCtD
Trimipramine—Dermatitis—Temozolomide—brain cancer	0.000207	0.00173	CcSEcCtD
Trimipramine—ADRA2A—endocrine gland—brain cancer	0.000207	0.00156	CbGeAlD
Trimipramine—Headache—Temozolomide—brain cancer	0.000206	0.00172	CcSEcCtD
Trimipramine—ADRA2A—head—brain cancer	0.000205	0.00154	CbGeAlD
Trimipramine—Nausea—Carmustine—brain cancer	0.000202	0.00169	CcSEcCtD
Trimipramine—HTR2A—midbrain—brain cancer	0.000201	0.00151	CbGeAlD
Trimipramine—HTR2A—spinal cord—brain cancer	0.000196	0.00147	CbGeAlD
Trimipramine—Nausea—Temozolomide—brain cancer	0.000196	0.00163	CcSEcCtD
Trimipramine—ADRA1A—brain—brain cancer	0.000195	0.00146	CbGeAlD
Trimipramine—DRD2—brain—brain cancer	0.000191	0.00143	CbGeAlD
Trimipramine—HRH1—central nervous system—brain cancer	0.00019	0.00143	CbGeAlD
Trimipramine—Asthenia—Etoposide—brain cancer	0.000189	0.00158	CcSEcCtD
Trimipramine—ADRA2A—central nervous system—brain cancer	0.000187	0.0014	CbGeAlD
Trimipramine—Pruritus—Etoposide—brain cancer	0.000186	0.00156	CcSEcCtD
Trimipramine—ABCB1—telencephalon—brain cancer	0.000183	0.00137	CbGeAlD
Trimipramine—ADRA2A—cerebellum—brain cancer	0.000183	0.00137	CbGeAlD
Trimipramine—Diarrhoea—Etoposide—brain cancer	0.00018	0.00151	CcSEcCtD
Trimipramine—HTR2A—endocrine gland—brain cancer	0.000176	0.00132	CbGeAlD
Trimipramine—Dizziness—Etoposide—brain cancer	0.000174	0.00145	CcSEcCtD
Trimipramine—HTR2A—head—brain cancer	0.000174	0.00131	CbGeAlD
Trimipramine—Vomiting—Etoposide—brain cancer	0.000168	0.0014	CcSEcCtD
Trimipramine—Rash—Etoposide—brain cancer	0.000166	0.00139	CcSEcCtD
Trimipramine—Dermatitis—Etoposide—brain cancer	0.000166	0.00139	CcSEcCtD
Trimipramine—Headache—Etoposide—brain cancer	0.000165	0.00138	CcSEcCtD
Trimipramine—CYP3A4—endocrine gland—brain cancer	0.000163	0.00122	CbGeAlD
Trimipramine—CYP2D6—endocrine gland—brain cancer	0.000161	0.0012	CbGeAlD
Trimipramine—HTR2A—central nervous system—brain cancer	0.000159	0.00119	CbGeAlD
Trimipramine—CYP2D6—head—brain cancer	0.000159	0.00119	CbGeAlD
Trimipramine—Nausea—Etoposide—brain cancer	0.000157	0.00131	CcSEcCtD
Trimipramine—HTR2A—cerebellum—brain cancer	0.000155	0.00116	CbGeAlD
Trimipramine—ABCB1—gonad—brain cancer	0.000153	0.00115	CbGeAlD
Trimipramine—HRH1—brain—brain cancer	0.000151	0.00113	CbGeAlD
Trimipramine—ABCB1—pituitary gland—brain cancer	0.000149	0.00112	CbGeAlD
Trimipramine—ADRA2A—brain—brain cancer	0.000148	0.00111	CbGeAlD
Trimipramine—CYP3A4—central nervous system—brain cancer	0.000147	0.0011	CbGeAlD
Trimipramine—CYP2D6—central nervous system—brain cancer	0.000145	0.00109	CbGeAlD
Trimipramine—ABCB1—medulla oblongata—brain cancer	0.000144	0.00108	CbGeAlD
Trimipramine—CYP2D6—cerebellum—brain cancer	0.000142	0.00106	CbGeAlD
Trimipramine—ABCB1—midbrain—brain cancer	0.000132	0.000986	CbGeAlD
Trimipramine—ABCB1—spinal cord—brain cancer	0.000128	0.000962	CbGeAlD
Trimipramine—HTR2A—brain—brain cancer	0.000126	0.000946	CbGeAlD
Trimipramine—ABCB1—endocrine gland—brain cancer	0.000116	0.000866	CbGeAlD
Trimipramine—CYP2D6—brain—brain cancer	0.000115	0.000862	CbGeAlD
Trimipramine—ABCB1—head—brain cancer	0.000114	0.000855	CbGeAlD
Trimipramine—ABCB1—central nervous system—brain cancer	0.000104	0.000781	CbGeAlD
Trimipramine—ABCB1—cerebellum—brain cancer	0.000102	0.000763	CbGeAlD
Trimipramine—ABCB1—brain—brain cancer	8.27e-05	0.00062	CbGeAlD
Trimipramine—HTR1D—GPCR downstream signaling—IL2—brain cancer	1.13e-05	0.000291	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	1.13e-05	0.00029	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTCH1—brain cancer	1.12e-05	0.000289	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SMO—brain cancer	1.12e-05	0.000289	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PDGFRA—brain cancer	1.11e-05	0.000286	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SHH—brain cancer	1.1e-05	0.000284	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	1.1e-05	0.000283	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	1.09e-05	0.00028	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—IDH1—brain cancer	1.09e-05	0.00028	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.08e-05	0.000279	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SPP1—brain cancer	1.08e-05	0.000278	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—IDH1—brain cancer	1.08e-05	0.000277	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TRPC6—brain cancer	1.06e-05	0.000274	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NOTCH2—brain cancer	1.06e-05	0.000274	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.06e-05	0.000272	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	1.05e-05	0.000271	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VAV1—brain cancer	1.05e-05	0.00027	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—IL2—brain cancer	1.05e-05	0.00027	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTCH1—brain cancer	1.04e-05	0.000269	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SMO—brain cancer	1.04e-05	0.000269	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	1.04e-05	0.000267	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.04e-05	0.000267	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.03e-05	0.000266	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL2—brain cancer	1.03e-05	0.000264	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.02e-05	0.000262	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.01e-05	0.000261	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VAV1—brain cancer	1.01e-05	0.000261	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	1.01e-05	0.00026	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VAV1—brain cancer	1.01e-05	0.000259	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IRS2—brain cancer	9.76e-06	0.000251	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP2C9—brain cancer	9.71e-06	0.00025	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VAV1—brain cancer	9.65e-06	0.000248	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.62e-06	0.000248	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	9.56e-06	0.000246	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	9.42e-06	0.000243	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	9.4e-06	0.000242	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	9.38e-06	0.000242	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ENO2—brain cancer	9.34e-06	0.00024	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NOTCH2—brain cancer	9.33e-06	0.00024	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	9.21e-06	0.000237	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	9.18e-06	0.000236	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NOTCH2—brain cancer	9.16e-06	0.000236	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ENO2—brain cancer	9.11e-06	0.000235	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HES1—brain cancer	9.02e-06	0.000232	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	8.99e-06	0.000231	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—VEGFA—brain cancer	8.92e-06	0.00023	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VAV1—brain cancer	8.89e-06	0.000229	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TP53—brain cancer	8.88e-06	0.000229	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.77e-06	0.000226	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VAV1—brain cancer	8.75e-06	0.000225	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—IL2—brain cancer	8.74e-06	0.000225	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VAV1—brain cancer	8.73e-06	0.000225	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HES1—brain cancer	8.71e-06	0.000224	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HES1—brain cancer	8.67e-06	0.000223	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—APC—brain cancer	8.62e-06	0.000222	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PIK3CG—brain cancer	8.62e-06	0.000222	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	8.59e-06	0.000221	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ENO2—brain cancer	8.59e-06	0.000221	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VAV1—brain cancer	8.57e-06	0.000221	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	8.56e-06	0.00022	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ENO2—brain cancer	8.51e-06	0.000219	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—IL2—brain cancer	8.44e-06	0.000217	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—IL2—brain cancer	8.39e-06	0.000216	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	8.35e-06	0.000215	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SPP1—brain cancer	8.34e-06	0.000215	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HES1—brain cancer	8.3e-06	0.000214	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	8.29e-06	0.000214	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—BSG—brain cancer	8.26e-06	0.000213	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	8.25e-06	0.000212	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SPP1—brain cancer	8.05e-06	0.000207	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	8.03e-06	0.000207	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SPP1—brain cancer	8.01e-06	0.000206	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VAV1—brain cancer	7.96e-06	0.000205	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL2—brain cancer	7.94e-06	0.000204	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	7.9e-06	0.000203	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—EGFR—brain cancer	7.85e-06	0.000202	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SPP1—brain cancer	7.67e-06	0.000197	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL2—brain cancer	7.66e-06	0.000197	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HES1—brain cancer	7.65e-06	0.000197	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL2—brain cancer	7.62e-06	0.000196	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IRS2—brain cancer	7.54e-06	0.000194	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HES1—brain cancer	7.53e-06	0.000194	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HES1—brain cancer	7.51e-06	0.000193	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—IL2—brain cancer	7.41e-06	0.000191	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HES1—brain cancer	7.37e-06	0.00019	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL2—brain cancer	7.3e-06	0.000188	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—IL2—brain cancer	7.29e-06	0.000188	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PDGFRA—brain cancer	7.28e-06	0.000187	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IRS2—brain cancer	7.28e-06	0.000187	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—IL2—brain cancer	7.27e-06	0.000187	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IRS2—brain cancer	7.24e-06	0.000187	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	7.17e-06	0.000184	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PDGFRA—brain cancer	7.15e-06	0.000184	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	7.14e-06	0.000184	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—IDH1—brain cancer	7.1e-06	0.000183	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SPP1—brain cancer	7.07e-06	0.000182	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	7.02e-06	0.000181	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SPP1—brain cancer	6.96e-06	0.000179	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SPP1—brain cancer	6.94e-06	0.000179	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IRS2—brain cancer	6.93e-06	0.000179	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HES1—brain cancer	6.85e-06	0.000176	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SPP1—brain cancer	6.81e-06	0.000175	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TP53—brain cancer	6.74e-06	0.000173	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—RELA—brain cancer	6.74e-06	0.000173	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL2—brain cancer	6.73e-06	0.000173	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ERBB2—brain cancer	6.69e-06	0.000172	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—APC—brain cancer	6.66e-06	0.000172	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	6.66e-06	0.000172	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	6.63e-06	0.000171	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL2—brain cancer	6.62e-06	0.00017	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL2—brain cancer	6.6e-06	0.00017	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	6.52e-06	0.000168	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL2—brain cancer	6.48e-06	0.000167	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	6.43e-06	0.000166	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—APC—brain cancer	6.43e-06	0.000166	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—APC—brain cancer	6.4e-06	0.000165	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	6.4e-06	0.000165	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IRS2—brain cancer	6.39e-06	0.000165	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SPP1—brain cancer	6.33e-06	0.000163	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IRS2—brain cancer	6.29e-06	0.000162	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IRS2—brain cancer	6.28e-06	0.000162	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IRS2—brain cancer	6.16e-06	0.000159	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	6.12e-06	0.000158	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—APC—brain cancer	6.12e-06	0.000158	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	6.07e-06	0.000156	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL2—brain cancer	6.07e-06	0.000156	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CG—brain cancer	6.04e-06	0.000156	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL2—brain cancer	6.02e-06	0.000155	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCND1—brain cancer	5.91e-06	0.000152	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—EGFR—brain cancer	5.86e-06	0.000151	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CTNNB1—brain cancer	5.86e-06	0.000151	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—EGFR—brain cancer	5.83e-06	0.00015	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IRS2—brain cancer	5.72e-06	0.000147	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CG—brain cancer	5.65e-06	0.000145	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—APC—brain cancer	5.65e-06	0.000145	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ENO2—brain cancer	5.61e-06	0.000145	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	5.58e-06	0.000144	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	5.56e-06	0.000143	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—APC—brain cancer	5.56e-06	0.000143	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—APC—brain cancer	5.54e-06	0.000143	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CG—brain cancer	5.54e-06	0.000143	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APC—brain cancer	5.44e-06	0.00014	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	5.44e-06	0.00014	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RELA—brain cancer	5.21e-06	0.000134	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	5.17e-06	0.000133	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—brain cancer	5.16e-06	0.000133	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—EGFR—brain cancer	5.14e-06	0.000132	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—STAT3—brain cancer	5.11e-06	0.000131	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—EGFR—brain cancer	5.06e-06	0.00013	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APC—brain cancer	5.05e-06	0.00013	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	5.05e-06	0.00013	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—EGFR—brain cancer	5.05e-06	0.00013	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RELA—brain cancer	5.02e-06	0.000129	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RELA—brain cancer	5e-06	0.000129	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ERBB2—brain cancer	4.99e-06	0.000129	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ERBB2—brain cancer	4.97e-06	0.000128	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	4.96e-06	0.000128	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RELA—brain cancer	4.79e-06	0.000123	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	4.76e-06	0.000122	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MYC—brain cancer	4.74e-06	0.000122	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL2—brain cancer	4.69e-06	0.000121	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—EGFR—brain cancer	4.64e-06	0.000119	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	4.6e-06	0.000119	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCND1—brain cancer	4.57e-06	0.000118	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	4.53e-06	0.000117	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL2—brain cancer	4.53e-06	0.000117	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL2—brain cancer	4.5e-06	0.000116	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RELA—brain cancer	4.41e-06	0.000114	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCND1—brain cancer	4.41e-06	0.000114	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCND1—brain cancer	4.39e-06	0.000113	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ERBB2—brain cancer	4.38e-06	0.000113	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	4.37e-06	0.000112	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	4.35e-06	0.000112	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RELA—brain cancer	4.34e-06	0.000112	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RELA—brain cancer	4.33e-06	0.000112	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ERBB2—brain cancer	4.31e-06	0.000111	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL2—brain cancer	4.31e-06	0.000111	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ERBB2—brain cancer	4.3e-06	0.000111	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.28e-06	0.00011	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RELA—brain cancer	4.25e-06	0.000109	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	4.22e-06	0.000109	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCND1—brain cancer	4.2e-06	0.000108	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CG—brain cancer	4.18e-06	0.000108	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	4.16e-06	0.000107	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	3.98e-06	0.000103	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—brain cancer	3.97e-06	0.000102	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RELA—brain cancer	3.95e-06	0.000102	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—brain cancer	3.94e-06	0.000102	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CG—brain cancer	3.94e-06	0.000101	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	3.92e-06	0.000101	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—brain cancer	3.91e-06	0.000101	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CG—brain cancer	3.9e-06	0.000101	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—brain cancer	3.9e-06	0.0001	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—brain cancer	3.9e-06	0.0001	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—brain cancer	3.87e-06	9.97e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—brain cancer	3.85e-06	9.9e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CTNNB1—brain cancer	3.84e-06	9.88e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—brain cancer	3.83e-06	9.86e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—brain cancer	3.83e-06	9.85e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—brain cancer	3.81e-06	9.81e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—brain cancer	3.81e-06	9.8e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—brain cancer	3.8e-06	9.79e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—brain cancer	3.79e-06	9.75e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	3.77e-06	9.72e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.77e-06	9.7e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—brain cancer	3.73e-06	9.61e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	3.7e-06	9.51e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—brain cancer	3.67e-06	9.44e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	3.66e-06	9.43e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—brain cancer	3.63e-06	9.34e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—brain cancer	3.59e-06	9.23e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—brain cancer	3.56e-06	9.16e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—brain cancer	3.54e-06	9.11e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—brain cancer	3.52e-06	9.06e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—brain cancer	3.47e-06	8.93e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—brain cancer	3.46e-06	8.91e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—brain cancer	3.44e-06	8.87e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	3.43e-06	8.84e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—brain cancer	3.38e-06	8.69e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—brain cancer	3.37e-06	8.68e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—brain cancer	3.34e-06	8.61e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—brain cancer	3.32e-06	8.55e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—brain cancer	3.32e-06	8.54e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.3e-06	8.49e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—brain cancer	3.29e-06	8.47e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—brain cancer	3.28e-06	8.45e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.25e-06	8.38e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.22e-06	8.29e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—brain cancer	3.11e-06	8e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—brain cancer	3.06e-06	7.87e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—brain cancer	3.05e-06	7.85e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—brain cancer	3.04e-06	7.82e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	3.02e-06	7.78e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—brain cancer	3.01e-06	7.75e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—brain cancer	2.99e-06	7.71e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—brain cancer	2.99e-06	7.71e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—brain cancer	2.99e-06	7.7e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—brain cancer	2.98e-06	7.68e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—brain cancer	2.93e-06	7.54e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—brain cancer	2.91e-06	7.48e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—brain cancer	2.89e-06	7.44e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—brain cancer	2.78e-06	7.16e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—brain cancer	2.77e-06	7.13e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—brain cancer	2.72e-06	7e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.58e-06	6.63e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—brain cancer	2.55e-06	6.57e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—brain cancer	2.51e-06	6.46e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—brain cancer	2.51e-06	6.45e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—brain cancer	2.46e-06	6.33e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—brain cancer	2.28e-06	5.88e-05	CbGpPWpGaD
